Ongoing research focused on deciphering the mechanisms of intercellular communication via EVs in the context of TGF-β-regulated cancer cell plasticity is poised to yield more precise and effective therapeutic strategies, potentially targeting specific EV subsets or interfering with their cargo-mediated effects on TGF-β signaling in recipient cells. This evidence concerns the gene TGFB1 and cancer.